Keyphrases
Prognostic Biomarker
100%
Cervical Cancer Patients
100%
Radiotherapy Response
100%
MicroRNA-21 (miR-21)
100%
MicroRNA-145
100%
Cervical Cancer
62%
Radioresistance
50%
Treatment Response
25%
Prediction Accuracy
12%
Quantitative PCR
12%
Chain Reaction
12%
Patient Outcomes
12%
Radiation Therapy
12%
Disease Progression
12%
Effective Treatment
12%
High-level Expression
12%
MicroRNA
12%
Predictive Power
12%
Cancer Stage
12%
Predictive Biomarker
12%
Reverse-time
12%
Response to Radiation
12%
Definitive Radiotherapy
12%
Nursing and Health Professions
Biological Marker
100%
Uterine Cervix Cancer
100%
microRNA 21
100%
microRNA 145
100%
Radiotherapy
100%
Radiosensitivity
50%
Area under the Curve
37%
Treatment Response
25%
Cross-Sectional Study
12%
Treatment Outcome
12%
Cancer Staging
12%
Disease Exacerbation
12%
Carcinogenesis
12%
microRNA
12%
Medicine and Dentistry
Biological Marker
100%
Cervical Cancer
100%
microRNA 21
100%
Mir-145
100%
Radiation Therapy
100%
Radiosensitivity
50%
Treatment Response
25%
Cross Sectional Study
12%
Cancer
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Carcinogenesis
12%
Disease Exacerbation
12%
microRNA
12%
Cancer Staging
12%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Uterine Cervix Cancer
100%
microRNA 21
100%
microRNA 145
100%
Cross-Sectional Study
12%
Carcinogenesis
12%
Disease Exacerbation
12%
Cancer Staging
12%
microRNA
12%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Mir-145
100%
Radiosensitivity
44%
Carcinogenesis
11%
Cross Sectional Study
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Cancer Staging
11%
Immunology and Microbiology
Radioresistance
100%
Prognostic Biomarker
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Cancer Staging
25%